WAYMED Endo
Commercial- Indications
- Gastrointestinal diseases
Company intelligence / Profile preview
WAYCEN
Seoul, Seoul Special City, South Koreaen.waycen.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
WAYCEN’s flagship product, WAYMED Endo, has been designated as an innovative medical device by the Korean Ministry of Food and Drug Safety for real-time AI-assisted gastric cancer detection during endoscopy. The company has commercial deployments in Korea and Vietnam and recently entered the Middle Eastern market through a partnership with MegaMind. Clinical results have led to national hospital adoption and regulatory recognition for innovation.
- Therapeutic areas
- OncologyPulmonology
- Modalities
- Device (AI-based diagnostic software)Non-pharmacological therapy (AI-enabled diagnostics)
- Industry
- Digital Health Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
MegaMind IT Solution (Middle East distribution partner)
Beyond the preview
Go deeper on WAYCEN.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on WAYCEN.